Literature DB >> 17034583

Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi.

A B Reis1, A Teixeira-Carvalho, R C Giunchetti, L L Guerra, M G Carvalho, W Mayrink, O Genaro, R Corrêa-Oliveira, O A Martins-Filho.   

Abstract

Canine visceral leishmaniasis (CVL) manifests itself as a broad clinical spectrum ranging from asymptomatic infection to patent severe disease. Despite relevant findings suggesting changes on lymphocytes subsets regarding the CVL clinical forms, it still remains to be elucidated whether a distinct phenotypic profile would be correlated with degree of tissue parasite density. Herein, we have assessed the correlation between the clinical status as well as the impact of bone marrow parasite density on the phenotypic profile of peripheral blood leucocytes in 40 Brazilian dogs naturally infected by Leishmania chagasi. Our major findings describe the lower frequency of B cells and monocytes as the most important markers of severe CVL. Our main statistically significant findings reveal that the CD8(+) T cell subset reflects most accurately both the clinical status and the overall bone marrow parasite density, as increased levels of CD8(+) lymphocytes appeared as the major phenotypic feature of asymptomatic disease and dogs bearing a low parasite load. Moreover, enhanced major histocompatibility complex (MHC)-II density as well as a higher CD45RB/CD45RA expression index seems to represent a key element to control disease morbidity. The association between clinical status, bone marrow parasitism and CD8(+) T cells re-emphasizes the role of the T cell-mediated immune response in the resistance mechanisms during ongoing CVL. Higher levels of circulating T lymphocytes (both CD4(+) and CD8(+) T cells) and lower MHC-II expression by peripheral blood lymphocytes seem to be the key for the effective immunological response, a hallmark of asymptomatic CVL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034583      PMCID: PMC1942052          DOI: 10.1111/j.1365-2249.2006.03206.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  Regulation of cell-mediated immunity in leishmaniasis.

Authors:  F Y Liew
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment.

Authors:  F Mancianti; M Gramiccia; L Gradoni; S Pieri
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

3.  Variation of MHC II expression on canine lymphocytes with age.

Authors:  M A Holmes; D P Lunn
Journal:  Tissue Antigens       Date:  1994-03

4.  Phagocytosis of Leishmania infantum promastigotes by monocytes isolated from Leishmania-infected dogs.

Authors:  O Brandonisio; L Ceci; M C Cedola; G Caretto; S Antonaci; E Jirillo
Journal:  Microbiologica       Date:  1986-04

Review 5.  Control of zoonotic visceral leishmaniasis: is it time to change strategies?

Authors:  R B Tesh
Journal:  Am J Trop Med Hyg       Date:  1995-03       Impact factor: 2.345

6.  An experimental model for canine visceral leishmaniasis.

Authors:  P Abranches; G Santos-Gomes; N Rachamim; L Campino; L F Schnur; C L Jaffe
Journal:  Parasite Immunol       Date:  1991-09       Impact factor: 2.280

7.  Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW).

Authors:  S Cobbold; S Metcalfe
Journal:  Tissue Antigens       Date:  1994-03

8.  Immunological and histological study of T- and B-lymphocyte activity in canine visceral leishmaniosis.

Authors:  A Martínez-Moreno; M S Martínez-Cruz; A Blanco; S Hernández-Rodríguez
Journal:  Vet Parasitol       Date:  1993-12       Impact factor: 2.738

9.  Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

Authors:  E Pinelli; R M Gonzalo; C J Boog; V P Rutten; D Gebhard; G del Real; E J Ruitenberg
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

10.  Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum.

Authors:  E Pinelli; R Killick-Kendrick; J Wagenaar; W Bernadina; G del Real; J Ruitenberg
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

View more
  29 in total

1.  Evaluation of the influence of tissue parasite density on hematological and phenotypic cellular parameters of circulating leukocytes and splenocytes during ongoing canine visceral leishmaniasis.

Authors:  L L Guerra; A Teixeira-Carvalho; R C Giunchetti; O A Martins-Filho; A B Reis; R Corrêa-Oliveira
Journal:  Parasitol Res       Date:  2008-11-05       Impact factor: 2.289

2.  Hepatic extracellular matrix alterations in dogs naturally infected with Leishmania (Leishmania) chagasi.

Authors:  Ferdinan Almeida Melo; Eliane Perlatto Moura; Raul Rio Ribeiro; Cíntia Fontes Alves; Marcelo Vidigal Caliari; Washington Luiz Tafuri; Kátia da Silva Calabrese; Wagner Luiz Tafuri
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

Review 3.  The balancing act: Immunology of leishmaniosis.

Authors:  Angela J Toepp; Christine A Petersen
Journal:  Res Vet Sci       Date:  2020-02-11       Impact factor: 2.534

4.  Influence of clinical status and parasite load on erythropoiesis and leucopoiesis in dogs naturally infected with leishmania (Leishmania) chagasi.

Authors:  Raquel Trópia de Abreu; Maria das Graças Carvalho; Cláudia Martins Carneiro; Rodolfo Cordeiro Giunchetti; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Wendel Coura-Vital; Rodrigo Corrêa-Oliveira; Alexandre Barbosa Reis
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

5.  Methods of Control of the Leishmania infantum Dog Reservoir: State of the Art.

Authors:  Michele Podaliri Vulpiani; Luigi Iannetti; Daniela Paganico; Filomena Iannino; Nicola Ferri
Journal:  Vet Med Int       Date:  2011-07-07

6.  Cytokine and Phenotypic Cell Profiles of Leishmania infantum Infection in the Dog.

Authors:  Carla Maia; Lenea Campino
Journal:  J Trop Med       Date:  2011-08-09

7.  Higher expression of CCL2, CCL4, CCL5, CCL21, and CXCL8 chemokines in the skin associated with parasite density in canine visceral leishmaniasis.

Authors:  Daniel Menezes-Souza; Renata Guerra-Sá; Cláudia Martins Carneiro; Juliana Vitoriano-Souza; Rodolfo Cordeiro Giunchetti; Andréa Teixeira-Carvalho; Denise Silveira-Lemos; Guilherme Corrêa Oliveira; Rodrigo Corrêa-Oliveira; Alexandre Barbosa Reis
Journal:  PLoS Negl Trop Dis       Date:  2012-04-10

8.  Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation.

Authors:  Bruno Mendes Roatt; Rodrigo Dian de Oliveira Aguiar-Soares; Juliana Vitoriano-Souza; Wendel Coura-Vital; Samuel Leôncio Braga; Rodrigo Corrêa-Oliveira; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; Marta de Lana; Nelder Figueiredo Gontijo; Marcos José Marques; Rodolfo Cordeiro Giunchetti; Alexandre Barbosa Reis
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

9.  Vaccines for canine leishmaniasis.

Authors:  Clarisa B Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

10.  In vitro binding and survival assays of Leishmania parasites to peripherical blood monocytes and monocyte-derived macrophages isolated from dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi.

Authors:  Weverton M Sampaio; Eliane P Moura; Felipe C S Arruda; Raul R Ribeiro; Cíntia F Alves; Ferdinan A Melo; Ana Paula S M Fernandes; Marilene S M Michalick; Maria N Melo; Washington L Tafuri; Wagner L Tafuri
Journal:  BMC Vet Res       Date:  2007-05-30       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.